Ozempic and Wegovy: new advantages for women’s health outweigh weight loss and diabetes

Semaglutide-based medications, such as Ozempic and Wegovy, have demonstrated beneficial impacts that go far beyond simple weight loss and blood sugar control, presenting especially promising results for women’s health. Although originally designed to treat type 2 diabetes and overweight, these drugs in the GLP-1 agonist class are increasingly being used to manage metabolic and hormonal conditions that are quite common among women.
The use of these treatments has shown a considerable impact on the management of Polycystic Ovary Syndrome (PCOS), a condition characterized by insulin resistance, irregular menstrual cycles and difficulties conceiving. By restoring insulin sensitivity and reducing body fat, semaglutide works to reduce the excessive production of androgens, male hormones that often cause acne, hair loss and unwanted hair in women affected by PCOS.

Another important consequence observed is the spontaneous resumption of ovulation in patients with fertility challenges, often related to obesity or PCOS itself. Doctors and specialists have noticed an increase in pregnancies among women using these medications. However, this observation requires extra caution, as treatment with semaglutide must be stopped immediately in case of confirmed pregnancy, due to the risk of complications in fetal development.
In the context of heart health, studies indicate that Wegovy can reduce the risk of serious cardiovascular events, such as heart attacks and strokes, by up to 20%. This information is of great value to women in the post-menopausal phase, a period in which the decrease in estrogen levels significantly increases the predisposition to heart problems.
The use of semaglutide also requires strict medical monitoring, especially in relation to its interaction with oral contraceptives and possible changes in the menstrual cycle. The process of delayed gastric emptying, caused by the medication, can influence the absorption of other medications administered orally, requiring specialized guidance to prevent contraceptive failures and other severe side effects.






